Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 18, Number 7—July 2012

Research

Validity of International Health Regulations in Reporting Emerging Infectious Diseases

Michael EdelsteinComments to Author , David L. Heymann, Johan Giesecke, and Julius Weinberg

Author affiliations: London School of Hygiene and Tropical Medicine, London, UK (M. Edelstein, D.L. Heymann); Chatham House, London (D.L. Heymann); European Centre for Disease Control, Stockholm, Sweden (J. Giesecke); and Kingston University, London (J. Weinberg)

Main Article

Table 3

Characteristics of 46 EID events of international public health concern reported to WHO*

Characteristic No. (%)
Type of pathogen
Bacterium 21 (45.6)
Virus 18 (39.1)
Rickettsia 2 (4.3)
Protozoan 3 (6.5)
Other† 2 (4.3)
WHO region
AMRO 17 (37.0)
EURO 12 (26.1)
EMRO 3 (6.5)
SEARO 2 (4.3)
WPRO 7(15.2)
AFRO 5 (10.9)
Type of event
New pathogen 19 (41.3)
Increased incidence 18 (39.1)
Antimicrobial drug resistance 8 (17.4)
New clinical manifestation 1 (2.2)

*EID, emerging infectious disease; WHO, World Health Organization; AMRO, Americas; EURO, Europe; EMRO, Eastern Mediterranean; SEARO, Southeast Asia; WPRO, Western Pacific; AFRO, Africa.
†Helminth, prion, or fungus.

Main Article

TOP